A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in patients…

New research reveals a surprising downside to calorie-cutting diets: a link to higher levels of depressive symptoms, especially in men and those who are overweight. Despite popular beliefs that healthy…

Findings reveal that sugary drink labels lead to minor changes in children's beverage selections, pointing to the necessity for effective labeling strategies.

The VIPTour AI system empowers visually impaired individuals to explore unfamiliar environments, enhancing emotional engagement and cognitive mapping accuracy.

This study presents an intrinsic capacity clock, using blood samples to predict mortality risk and enhance understanding of aging and lifestyle impacts.

Every tumor is unique. This makes it difficult to find the most effective therapy for treatment. The Tumor Profiler Center of the University Hospital Zurich, the University of Zurich, ETH…

In 2022, Western Europe experienced the largest surge in reported diphtheria infections in 70 years. Clinical and genomic data from the outbreak point toward transmission routes along established migration pathways…

A study led by biomedical scientists at the University of California, Riverside School of Medicine shows how a genetic mutation associated with Crohn's disease can worsen iron deficiency and anemia…

Picture a living cell as if it were a city. If you were the urban planner for this (very little, very alive) city, one of the things you would have…

A groundbreaking study led by National Jewish Health researchers suggests that the skin may serve as a potential biomarker for a chronic allergic disease of the esophagus called eosinophilic esophagitis…